Sign in

NCT07374237Completed

Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients With Good and Poor Sleep Quality

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

Multiple sclerosis (MS) is a chronic disease of the central nervous system associated with a wide range of motor and non-motor symptoms. Sleep disturbances, fatigue, altered interoceptive perception, and impairments in upper and lower extremity functional capacity are commonly observed in individuals with MS. Decreased sleep quality may exacerbate fatigue and negatively affect daily activities and independence. Therefore, examining the relationships between sleep quality, interoception, fatigue, and extremity functional capacity is essential for effective disease management and the preservation of quality of life in individuals with MS. The aim of this study is to compare interoception, fatigue, and upper and lower extremity functional capacity between individuals with MS who have good and poor sleep quality and to evaluate the relationships among these variables. By comparing MS patients based on sleep quality, this study seeks to clarify the impact of sleep quality on interoceptive processes, fatigue levels, and functional capacity.

Status (registry)
Completed
Study type
Observational
Enrollment
102 (actual)
First submitted
16 Jan 2026
Start date
1 Nov 2025
Primary completion date
1 Mar 2026
Lead sponsor
Gulhane School of Medicine
NCT number
NCT07374237

What you commit to

  • Study type: Observational
  • Participants enrolled: 102
  • From 1 Nov 2025 to the primary completion date, 1 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of corticosteroids within the last 4 weeks
  • Change in medication within the last month

Other illness

  • Presence of orthopedic conditions affecting the hip, knee, or ankle
  • History of surgery involving the spine, hip, knee, or ankle

Other

  • Pregnancy
  • Presence of spinal deformities, disc herniation, or other spinal pathologies

Who the study is looking for

  • Diagnosed with multiple sclerosis by a specialist physician
  • Aged between 18 and 65 years
  • No MS relapse within the last 3 months
  • Expanded Disability Status Scale (EDSS) score between 1.0 and 5.0
  • Ability to stand independently for at least 60 seconds without the use of any assistive device
  • No additional neurological disorder or circulatory/visual impairment that may affect balance
  • Cognitive function score \>24 on the Mini-Mental State Examination (MMSE)
  • Provided written informed consent after receiving detailed information about the study

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ankara Bilkent City Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.